FK506, Denudation of Donor Endothelial Cells and Bafilomycin A_1, a Selective Inhibitor of Vacuolar H^+-ATPase, Inhibit Neointimal Hyperplasia in Rat Cryopreserved Aortic Allograft

FK506,供体内皮细胞的剥脱和巴弗洛霉素 A_1(液泡 H+-ATP 酶的选择性抑制剂)抑制大鼠冷冻保存的同种异体主动脉移植物中的新内膜增生

基本信息

  • 批准号:
    14571289
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

Cryopreserved allografts have been utilized as alternatives for autografts. However, quality of allografts has been compromised by neointimal hyperplasia (NH). Although allo-immune response and cryopreservation procedures have been implicated in the mechanism of cryopreserved allograftpathy, the exact nature of this pathophysiology remains unknown. We have, therefore, investigated the possible involvement of allo-immune response and V-ATPase in NH in rat cryopreserved aortic allografts.Cryopreserved thoracic aorta from donor rats were implanted to the infra-renal abdominal aorta of recipient rats. The grafts removed 14 days after surgery were evaluated for all-immune response by counting the number of lymphocytes with positive immunostainung for CD8^+(×10^4/mm^2), and for NH by calculating the area ratio of intima to media.Allo-immune response in untreated allografts and allografts treated with Bafilomycin A_1 (BA_1) were significantly higher than untreated isografts, allografts treated with FK506 and allografts of which endothelial cell (ETs) were denuded (p<0.05). Untreated isografts and allografts of which ETs were denuded before transplantation and treated with FK506 and with BA_1 showed significant inhibition of NH compared to untreated allografts (p<0.05). Neointimal cells showed positive immunostaining for vimentin, but negative for HF-35 and CGA-7, indicating that these cells were dedifferentiated SMCs.FK506, denudation of donor ETs and BA_1 inhibit NH early after transplantation of rat cryopreserved aortic allografts. The mechanism of inhibition of NH induced by inhibition of allo-immune response may involve immunosuppression whereas that exerted by BA_1 may be mediated through direct growth suppression of dedifferentiated SMCs via inhibition of V-ATPase.
冷冻保存的同种异体移植物已被用作自体移植物的替代品。然而,同种异体移植物的质量已受到新生内膜增生(NH)的影响。虽然同种免疫反应和冷冻保存程序已被牵连在冷冻保存同种异体移植病的机制,这种病理生理学的确切性质仍然未知。因此,我们研究了同种异体免疫反应和V-ATPase在大鼠深低温保存的同种异体主动脉移植物NH中的可能参与。通过计数CD 8 ^+免疫染色阳性的淋巴细胞数量,评估术后14天取出的移植物的全免疫应答结果表明,未处理的同种异体移植物和BA_1处理的同种异体移植物的免疫反应均显著高于未处理的同种异体移植物,FK 506处理的同种异体移植物和内皮细胞剥脱的同种异体移植物(p<0.05)。与未处理的同种异体移植物相比,FK 506和BA_1处理的同种异体移植物和移植前剥脱血管的同种异体移植物对NH的抑制作用显著(p<0.05)。FK 506、供体血管剥脱和BA_1均能抑制大鼠同种异体主动脉移植后早期NH的发生。BA_1抑制NH的机制可能是通过抑制V-ATP酶而直接抑制去分化SMC的生长。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
大迫 茂登彦, 他8名: "凍結保存同種血管の内膜肥厚における拒絶反応の関与とその対策"脈管学. 42・4. 271-277 (2002)
Shigetohiko Osako等8人:“冷冻保存同种异体血管内膜增厚的排斥反应及其对策”血管学42・4(2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OSAKO Motohiko其他文献

OSAKO Motohiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OSAKO Motohiko', 18)}}的其他基金

Anastomotic Stenosis is a Cause of Intimal Hyperplasia at the Middle Portion of Arterial Graft
吻合口狭窄是移植动脉中部内膜增生的原因
  • 批准号:
    12671336
  • 财政年份:
    2000
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
用他汀类药物靶向转录共激活剂 YAP 和 TAZ,以防止 HLA 供体特异性抗体导致实体器官移植排斥
  • 批准号:
    10734277
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
  • 批准号:
    10658665
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Cell Therapy Program with Scale-up cGMP Manufacturing of Human Corneal Stromal Stem Cells
细胞治疗计划,扩大人类角膜基质干细胞的 cGMP 生产
  • 批准号:
    10720562
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft
同种异体移植肾中复发性肾小球疾病的遗传学和免疫预测因子
  • 批准号:
    10637158
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
  • 批准号:
    10642598
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Kynurenine-dependent redox signaling at the interface between innate and adaptive immunity
先天免疫和适应性免疫之间界面的犬尿氨酸依赖性氧化还原信号传导
  • 批准号:
    10749210
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Molecular Immunology Core
分子免疫学核心
  • 批准号:
    10622125
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Targeting trained immunity in transplantation
在移植中瞄准经过训练的免疫力
  • 批准号:
    10642592
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Elucidating the role of trained immunity in kidney transplant patients
阐明训练有素的免疫力在肾移植患者中的作用
  • 批准号:
    10642596
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了